Results 171 to 180 of about 49,507 (253)
[Congenital deficiency of antithrombin III].
Haematologica, 1990 G, Finazzi, T, Barbui
openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Congenital antithrombin III deficiency
The American Journal of Medicine, 1989Jack Hirsh, Franco Piovella, Mario Pini
openaire +2 more sources
Familial Antithrombin III Deficiency
The Lancet, 1983Antithrombin III is the major physiological inhibitor of the coagulation mechanism and a deficiency of this protein results in a marked predisposition to venous thromboembolic disease. Three Scottish families with a deficiency of this protein are described and other reported families are reviewed.
J H, Winter +6 more
+8 more sources
Blood Coagulation and Fibrinolysis, 2020
: The incidence of antithrombin III (AT III) deficiency is very rare. The most common complication of AT III deficiency is deep venous thrombosis, which causes a low incidence of intracranial sinus thrombosis.
F. Shang +4 more
semanticscholar +1 more source
: The incidence of antithrombin III (AT III) deficiency is very rare. The most common complication of AT III deficiency is deep venous thrombosis, which causes a low incidence of intracranial sinus thrombosis.
F. Shang +4 more
semanticscholar +1 more source
Venous Thrombosis: Antithrombin III Deficiency
Critical Care Nursing Clinics of North America, 1993Antithrombin (ATIII) is believed to be one of the body's most powerful natural anticoagulants, so individuals with a deficiency of this protein exhibit a marked propensity to venous thrombosis. This article will focus on the pathophysiology of this disorder, including clinical presentation, diagnosis, and treatment.
M, Halfman, D E, Berg
openaire +2 more sources
Familial Functional Antithrombin III Deficiency
Scandinavian Journal of Haematology, 1980A family with a tendency to thrombosis and decreased antithrombin III (AT III) activity in plasma, but normal immunoreactive AT III is reported. 7 members of the family had the AT III defect, 4 of whom have had thrombotic episodes. The importance of biological determination of AT III when studying patients with recurrent thrombotic episodes is ...
P J, Sørensen +3 more
openaire +2 more sources
Thrombosis Research, 1987
Antithrombin III (AT III) microheterogeneity was investigated in 12 cases of congenital AT III deficiency and 2 cases of congenital AT III abnormality by isoelectric focusing (IEF) and immunofixation. In congenital AT III deficiency, IEF and immunofixation revealed AT III as 8 bands which was indistinguishable from normal control in terms of the number
N, Sakuragawa +4 more
openaire +2 more sources
Antithrombin III (AT III) microheterogeneity was investigated in 12 cases of congenital AT III deficiency and 2 cases of congenital AT III abnormality by isoelectric focusing (IEF) and immunofixation. In congenital AT III deficiency, IEF and immunofixation revealed AT III as 8 bands which was indistinguishable from normal control in terms of the number
N, Sakuragawa +4 more
openaire +2 more sources
Congenital antithrombin III deficient neonate treated with antithrombin III concentrates
Thrombosis Research, 1993A patient with antithrombin III deficiency developed deep vein thrombosis during her first pregnancy. Her pregnancy and delivery were successfully treated with simultaneous administration of antithrombin III concentrates and low molecular weight heparin. She delivered a 2,412g girl at 39 weeks' gestation. The baby was administered with antithrombin III
A, Shiozaki +4 more
openaire +2 more sources